New blood test could spot breast cancer early, saving lives
NCT ID NCT07331506
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new blood test called Oncoliq to see if it can find breast cancer early. Researchers will collect blood from 300 women, some with breast cancer and some without, to check for tiny molecules called miRNAs that tumors release. The goal is to create a simple, affordable, and non-invasive test that could help catch breast cancer sooner, when it's easier to treat.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER - DUCTAL CARCINOMA IN SITU (DCIS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
DIM Centros de Salud
RECRUITINGBuenos Aires, Buenos Aires, B1704, Argentina
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Exercise during chemo: a new weapon to preserve strength?
- Can early sexual health counseling transform breast cancer recovery?
- Can a smart drug cross the Blood-Brain barrier to attack breast cancer metastases?
- Can a drug cocktail cure metastatic breast cancer? a trial aims to find out
- What helps or hinders a breast cancer referral? a study listens to Women's stories
- No-Squeeze 3D breast scan could transform cancer detection